Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

10.22
-0.4700-4.40%
Post-market: 8.90-1.3200-12.92%19:59 EDT
Volume:1.01M
Turnover:10.35M
Market Cap:890.74M
PE:-4.80
High:10.86
Open:10.79
Low:10.18
Close:10.69
52wk High:36.26
52wk Low:6.65
Shares:87.16M
Float Shares:71.89M
Volume Ratio:1.27
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:2.07
PE(LYR):-5.47

Loading ...

Olema Oncology Announces Encouraging Initial Clinical Data From the Phase 1 Study of Op-3136, a Kat6 Inhibitor, at 2026 Asco Annual Meeting

THOMSON REUTERS
·
May 22

J.P. Morgan Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
May 19

LifeSci Capital Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)

TIPRANKS
·
May 18

Citi opens ‘upside 90-day catalyst watch’ on Olema Oncology

TIPRANKS
·
May 14

Olema Pharmaceuticals Is Maintained at Buy by Guggenheim

Dow Jones
·
May 13

Stock Track | Olema Pharmaceuticals Plummets 5.01% Intraday Following Guggenheim Price Target Cut

Stock Track
·
May 13

Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts

TIPRANKS
·
May 13

Olema Oncology price target lowered to $35 from $38 at Guggenheim

TIPRANKS
·
May 13

Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating

TIPRANKS
·
May 13

Analysts’ Top Healthcare Picks: Olema Pharmaceuticals (OLMA), Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
May 13

Olema Pharmaceuticals Q1 EPS $(0.52) Beats $(0.53) Estimate

Benzinga Earnings
·
May 12

Earnings Flash (OLMA) Olema Pharmaceuticals Posts Q1 Net Loss $0.52 a Share, vs. FactSet Est of $0.52 Loss

MT Newswires Live
·
May 12

Olema Pharmaceuticals Q1 net loss widens on higher R&D costs

Reuters
·
May 12

Press Release: Olema Oncology Reports First Quarter 2026 Financial and Operating Results

Dow Jones
·
May 12

Olema Pharmaceuticals Q1 Net Income USD -53.089 Million

THOMSON REUTERS
·
May 12

Olema grants new-hire stock options for 154,700 shares at $14.32 each

Reuters
·
May 05

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 05

Olema Adds Deal Veteran Prakash Raman To Guide Oncology Partnerships

Simply Wall St.
·
May 03

Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point

TIPRANKS
·
May 02

Olema Pharmaceuticals Adds Veteran Director to Support Growth

TIPRANKS
·
Apr 30